glp 1 logo Discover How GLP-1 Trials Are Not One-Size-Fit-All GLP-1 Program: Enhance Strength &

While acute exposure to GLP-1 RAs during initiation or dose escalation is expected to delay gastric emptying, chronic use can lead to adaptive responses that attenuate this effect

Keep a clear history of your Zepbound, Wegovy, Ozempic, or Mounjaro shots and always stay on track

Owing to their effectiveness in reducing body weight, once-daily subcutaneous administration of liraglutide 3.0 mg has been approved, and once-weekly subcutaneous administration of semaglutide 2.4 mg is being investigated in phase III trials, for obesity management

GLP-1 medications, such as semaglutide (known by brand names like Ozempic or Wegovy), are a class of drugs originally designed to treat type 2 diabetes